(Q38631276)

4 September 2017

title

Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging? (English)

1 reference

4 September 2017

main subject

liver transplantation

1 reference

inferred from title

hepatocellular carcinoma

1 reference

Francis Y Yao

1

1 reference

4 September 2017

Nicholas Fidelman

series ordinal

2

1 reference

4 September 2017

language of work or name

English

0 references

publication date

11 November 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

63

1 reference

4 September 2017

issue

3

1 reference

4 September 2017

page(s)

1014-1025

1 reference

4 September 2017

cites work

Hepatocellular carcinoma

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

MELD Exceptions and Rates of Waiting List Outcomes.

21 January 2018

1 reference

Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients

21 January 2018

1 reference

OPTN/SRTR 2012 Annual Data Report: liver

21 January 2018

1 reference

Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria

21 January 2018

1 reference

Waitlist priority for hepatocellular carcinoma beyond milan criteria: a potentially appropriate decision without a structured approach

21 January 2018

1 reference

Hepatocellular carcinoma: Ablate and wait versus rapid transplantation

21 January 2018

1 reference

Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria

21 January 2018

1 reference

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.

21 January 2018

1 reference

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma

21 January 2018

1 reference

Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome

21 January 2018

1 reference

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

21 January 2018

1 reference

Benefit of downsizing hepatocellular carcinoma in a liver transplant population

21 January 2018

1 reference

Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization

21 January 2018

1 reference

Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria

21 January 2018

1 reference

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

21 January 2018

1 reference

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

21 January 2018

1 reference

Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction

21 January 2018

1 reference

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation

21 January 2018

1 reference

Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy

21 January 2018

1 reference

Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria

21 January 2018

1 reference

Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

21 January 2018

1 reference

7 January 2021

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

1 reference

7 January 2021

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

1 reference

7 January 2021

Downstaging of hepatocellular carcinoma before transplantation: an advance in therapy or just another selection criterion

1 reference

7 January 2021

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

7 January 2021

Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation

1 reference

7 January 2021

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

1 reference

7 January 2021

The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series

1 reference

7 January 2021

Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28139

1 reference

4 September 2017

1 reference